Terms: = Brain cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Treatment
106 results:
1. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
[TBL] [Abstract] [Full Text] [Related]
2. Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial.
Zhao S; Zhang M; Zhang Q; Wu J; Dai H
BMC Cancer; 2024 Jan; 24(1):6. PubMed ID: 38166698
[TBL] [Abstract] [Full Text] [Related]
3. Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma treatment.
Singh S; Barik D; Lawrie K; Mohapatra I; Prasad S; Naqvi AR; Singh A; Singh G
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834408
[TBL] [Abstract] [Full Text] [Related]
4. Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities.
Jones AB; Schanel TL; Rigsby MR; Griguer CE; McFarland BC; Anderson JC; Willey CD; Hjelmeland AB
Cells; 2023 Aug; 12(17):. PubMed ID: 37681903
[TBL] [Abstract] [Full Text] [Related]
5. Unraveling the signaling mechanism behind astrocytoma and possible therapeutics strategies: A comprehensive review.
Nahar Metu CL; Sutihar SK; Sohel M; Zohora F; Hasan A; Miah MT; Rani Kar T; Hossain MA; Rahman MH
Cancer Rep (Hoboken); 2023 Oct; 6(10):e1889. PubMed ID: 37675821
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase.
Gao T; Huang J; Yin H; Huang J; Xie J; Zhou T; Fan W; Yang X; Gao G; Li Z
Cell Death Dis; 2023 May; 14(5):316. PubMed ID: 37160920
[TBL] [Abstract] [Full Text] [Related]
7. Sorting nexin 10 sustains PDGF receptor signaling in glioblastoma stem cells via endosomal protein sorting.
Gimple RC; Zhang G; Wang S; Huang T; Lee J; Taori S; Lv D; Dixit D; Halbert ME; Morton AR; Kidwell RL; Dong Z; Prager BC; Kim LJ; Qiu Z; Zhao L; Xie Q; Wu Q; Agnihotri S; Rich JN
JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795488
[TBL] [Abstract] [Full Text] [Related]
8. Cardiovascular morbidity following conventional therapy versus allogeneic hematopoietic stem cell transplantation after childhood, adolescent, and young adult leukemia in Finland.
Kero AE; Taskinen M; Volin L; Löyttyniemi E; Itälä-Remes M; Lähteenmäki PM
Int J Cancer; 2023 Jun; 152(11):2292-2302. PubMed ID: 36760204
[TBL] [Abstract] [Full Text] [Related]
9. Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies.
Yao C; Wu S; Kong J; Sun Y; Bai Y; Zhu R; Li Z; Sun W; Zheng L
Cancer Biol Med; 2023 Jan; 20(1):25-43. PubMed ID: 36647777
[TBL] [Abstract] [Full Text] [Related]
10. Clinical outcomes of patients with multiple courses of radiosurgery for brain metastases from non-small cell lung cancer.
Lee WJ; Choi JW; Kong DS; Seol HJ; Nam DH; Lee JI
Sci Rep; 2022 Jun; 12(1):10712. PubMed ID: 35739135
[TBL] [Abstract] [Full Text] [Related]
11. PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38
Lane R; Cilibrasi C; Chen J; Shah K; Messuti E; Mazarakis NK; Stebbing J; Critchley G; Song E; Simon T; Giamas G
Oncogene; 2022 May; 41(19):2749-2763. PubMed ID: 35393545
[TBL] [Abstract] [Full Text] [Related]
12. Targeted therapy with anlotinib for a H3K27M mutation diffuse midline glioma patient with pdgfr-α mutation: a case report.
Wang Q; Niu W; Pan H
Acta Neurochir (Wien); 2022 Aug; 164(8):2063-2066. PubMed ID: 34812950
[TBL] [Abstract] [Full Text] [Related]
13. Gain of HIF1 Activity and Loss of miRNA
Wyss CB; Duffey N; Peyvandi S; Barras D; Martinez Usatorre A; Coquoz O; Romero P; Delorenzi M; Lorusso G; Rüegg C
Cancer Res; 2021 Feb; 81(3):594-605. PubMed ID: 33526470
[TBL] [Abstract] [Full Text] [Related]
14. PDGF receptor mutations in human diseases.
Guérit E; Arts F; Dachy G; Boulouadnine B; Demoulin JB
Cell Mol Life Sci; 2021 Apr; 78(8):3867-3881. PubMed ID: 33449152
[TBL] [Abstract] [Full Text] [Related]
15. Pediatric high-grade glioma: aberrant epigenetics and kinase signaling define emerging therapeutic opportunities.
Sun Y; Bailey CP; Sadighi Z; Zaky W; Chandra J
J Neurooncol; 2020 Oct; 150(1):17-26. PubMed ID: 32504402
[TBL] [Abstract] [Full Text] [Related]
16. Is surgery justified for 80-year-old or older intracranial meningioma patients? A systematic review.
Rautalin I; Niemelä M; Korja M
Neurosurg Rev; 2021 Apr; 44(2):1061-1069. PubMed ID: 32248508
[TBL] [Abstract] [Full Text] [Related]
17. Small molecule tyrosine kinase inhibitors in glioblastoma.
Kim G; Ko YT
Arch Pharm Res; 2020 Apr; 43(4):385-394. PubMed ID: 32239429
[TBL] [Abstract] [Full Text] [Related]
18. Applied Precision cancer Medicine in Neuro-Oncology.
Taghizadeh H; Müllauer L; Furtner J; Hainfellner JA; Marosi C; Preusser M; Prager GW
Sci Rep; 2019 Dec; 9(1):20139. PubMed ID: 31882734
[TBL] [Abstract] [Full Text] [Related]
19. Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines.
Alexandru O; Sevastre AS; Castro J; Artene SA; Tache DE; Purcaru OS; Sfredel V; Tataranu LG; Dricu A
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547056
[TBL] [Abstract] [Full Text] [Related]
20. Signal Transduction in Diffuse Intrinsic Pontine Glioma.
Duchatel RJ; Jackson ER; Alvaro F; Nixon B; Hondermarck H; Dun MD
Proteomics; 2019 Nov; 19(21-22):e1800479. PubMed ID: 31328874
[TBL] [Abstract] [Full Text] [Related]
[Next]
